mitomycin has been researched along with Medulloblastoma in 3 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)
Excerpt | Relevance | Reference |
---|---|---|
" Both dosage and releasing time can be adjusted." | 1.27 | [Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites]. ( Himuro, H; Inoue, N; Kaetsu, I; Kitamura, K; Kubo, O; Sakairi, M; Tajika, T; Tajika, Y; Tohyama, T; Yoshida, M, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Weeraratne, SD | 1 |
Amani, V | 1 |
Neiss, A | 1 |
Teider, N | 1 |
Scott, DK | 1 |
Pomeroy, SL | 1 |
Cho, YJ | 1 |
Kawakami, K | 1 |
Kawamoto, K | 1 |
Oka, N | 1 |
Kawamura, Y | 1 |
Matsumura, H | 1 |
Ito, T | 1 |
Ohyama, A | 1 |
Kubo, O | 1 |
Himuro, H | 1 |
Inoue, N | 1 |
Tajika, Y | 1 |
Tajika, T | 1 |
Tohyama, T | 1 |
Sakairi, M | 1 |
Yoshida, M | 1 |
Kaetsu, I | 1 |
Kitamura, K | 1 |
3 other studies available for mitomycin and Medulloblastoma
Article | Year |
---|---|
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Cyc | 2011 |
[Flow cytometric studies of brain tumors--5: New sensitivity test of antineoplastic agents for brain tumors and its clinical application].
Topics: Animals; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Cell Cycle; Cell Survival; Colony-Formin | 1986 |
[Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites].
Topics: Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Doxorubicin; Drug Implants; Dysge | 1986 |